Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Merus N.V. | Chief Financial Officer & PFO | Share Option (right to buy) | 107K | $1.45M | $13.52 | May 7, 2024 | Direct |
KALA BIO, Inc. | Director | Common Stock | 10.9K | $66.3K | $6.09 | Jun 11, 2024 | Direct |
Finch Therapeutics Group, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 80K | Feb 25, 2022 | Direct | ||
KALA BIO, Inc. | Director | Stock Option (right to buy) | 3.15K | Jun 11, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KALA | KALA BIO, Inc. | Jun 11, 2024 | 2 | $0 | 4 | Jun 12, 2024 | Director |
MRUS | Merus N.V. | May 7, 2024 | 1 | $0 | 4 | May 9, 2024 | Chief Financial Officer & PFO |
KALA | Kala Pharmaceuticals, Inc. | Jun 22, 2023 | 4 | $0 | 4 | Jun 23, 2023 | Director |
MRUS | Merus N.V. | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Chief Financial Officer |
MRUS | Merus N.V. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
KALA | Kala Pharmaceuticals, Inc. | May 31, 2023 | 4 | $0 | 4 | Jun 2, 2023 | Director |
KALA | Kala Pharmaceuticals, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
MRUS | Merus N.V. | May 31, 2022 | 1 | $0 | 4 | Jun 2, 2022 | Director |
FNCH | Finch Therapeutics Group, Inc. | Feb 25, 2022 | 1 | $0 | 4 | Feb 28, 2022 | Chief Financial Officer |
KALA | Kala Pharmaceuticals, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
MRUS | Merus N.V. | May 28, 2021 | 1 | $0 | 4 | Jun 2, 2021 | Director |